In 2023, the expenditure by private non-profits on R&D in the medical and health sciences sector in Japan stood at approximately 650 million USD PPP. From 2024 onwards, there is a steady year-on-year increase, with a growth rate of around 1.41% in 2025 and a similar trend continuing till 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) is approximately 1.38%. This demonstrates a moderate growth trajectory in private non-profit R&D investments in the sector.

Future trends to watch for include:

Potential changes in government policies affecting funding and tax incentives for R&D.
Technological advancements in medical sciences that could foster increased investment levels.
Global economic conditions impacting the exchange rates and purchasing power, influencing R&D budgets.